Delhi
Ranbaxy
develops, manufactures and markets pharmaceutical products... Read moreRanbaxy
develops, manufactures and markets pharmaceutical products... Read more
CEO
Add
News
Oct 22, 2024
Openpr
Ranbaxy: Anosmia Market to Witness Substantial Growth by 2031 | Mylan N.V., Pfizer Inc., Atom Pharma, Ranbaxy laboratories limited
Mar 07, 2024
Newstrail
Ranbaxy: Tolterodine Market: A Deep Value Opportunity| Pfizer, Ranbaxy, Sandoz
Feb 22, 2023
Pressbee
Ranbaxy: Former Ranbaxy, DRL exec Rajeev Raghuvanshi appointed as new DCGI
Sep 20, 2022
Law 360
Ranbaxy: 'Excessive' Atty Fee Bid In Ranbaxy MDL Slashed By $36M
Apr 29, 2022
Law 360
Ranbaxy: Ranbaxy Buyers' $485M Deal In Generics MDL Gets Initial Nod
Apr 22, 2022
Law 360
Ranbaxy: Ranbaxy Buyers Seek OK On $485M Deal In Generics MDL
Mar 24, 2022
Endpoints News
Ranbaxy: Sun Pharma shelling out $485M to settle US antitrust case against generics giant
Mar 24, 2022
Law 360
Ranbaxy: Ranbaxy Confirms 'Global' Deal Resolving Antitrust MDL
Mar 24, 2022
FiercePharma
Ranbaxy: Sun Pharma forks over $485M to settle long-running legal battle inherited in Ranbaxy buyout
Mar 24, 2022
STAT News
Ranbaxy: STAT+: Sun Pharmaceuticals to pay $485 million to settle claims its Ranbaxy unit caused customers to overpay for generics
Ranbaxy Competitors
1
2
3
4
5
6
7
8
9